Global Self-Monitoring Blood Glucose Devices Market to 2023 by Product Type, End-user Type and Region - ResearchAndMarkets.com

The "Global
Self-Monitoring Blood Glucose Devices Market (2018-2023)"
report has been added to ResearchAndMarkets.com's
offering.

The self-monitoring blood glucose devices market comprises testing
strips, glucometers and other product segments such as lancets and
lancing devices. Increase in aging population, high prevalence of
diabetes due to unhealthy lifestyle, poor diet, excess alcohol
consumption, and lack of physical activity, creates a huge demand for
blood glucose devices across the globe.

The global self-monitoring blood glucose devices market is forecast to
grow at a CAGR of 4.8% (2018-2023) and will reach USD 9.4 Bn in 2023
from USD 7.4 Bn in 2018. Market players are primarily focusing on
product launches, and mergers and acquisitions to broaden their customer
base, as well as to consolidate their position in the market.

Segmentation based on product type

Based on product type, in 2018, the testing strips segment contributed
the highest market share (78.8%), on account of its economical pricing
in comparison to glucose meters, and awareness among diabetes patients.
The glucometers segment was the second-largest segment, with a market
share of 16.1%, owing to its ease of use, painless procedure, and quick
results.

The other products' segment comprises lancets, lancing devices, etc. It
accounted for a 5.1% share of the market and is expected to show
moderate growth during the forecast period

Segmentation based on end-user type

Based on end-user type, the market is segmented into hospitals, home
settings, and diagnostics centers and clinics. Home settings segment
contributed the highest market share of 86.7% in 2018 and will continue
to grow at CAGR 4.9% due to convenience as these devices allow patients
to check their blood glucose levels at home, at their own convenience.

During the forecast period, diagnostic centres and clinics are expected
to expand at a moderate growth rate; in 2018, the segment witnessed a
market share of 8.5%. In 2018, the hospital segment demonstrated the
least market share of 4.7%; the segment is projected to expand at a
nominal growth in the coming years.

Regional insights

The self-monitoring blood glucose devices market in North America
accounted for the highest market share of 39.8% in 2018. The segment is
expected to increase at CAGR 4.2% from 2018-2023 owing to factors such
as a growing number of advanced medical facilities, rising healthcare
expenditure, and favourable reimbursement policies in the region. In
2018, testing strips segment contributed the highest revenue in the
North America region due to an increase in diabetes cases, increasing
disposable income, and technological advancements. The European market
is anticipated to expand at a CAGR of 4.6% during the forecast period,
given the presence of major market players in the region, improved
awareness, and availability of self-monitoring blood glucose devices in
a number of variants.

A large population, higher disposable income, and improved awareness
about self-monitoring blood glucose devices will help the Asia-Pacific
region dominate the global market during the forecast period. The Middle
East and Africa and the Latin America markets, though still at nascent
stages, will also experience high growth

Companies covered

• Roche Holding AG
• LifeScan Inc.
• Abbott Laboratories
• Ypsomed AG
• B. Braun Melsungen AG
• Ascensia Diabetes Care
• DiaMonTech
• Nemaura Medical Inc.
• Noviosense B.V.

Key Topics Covered

Chapter 1: Executive summary

1.1. Market scope and segmentation

1.2. Key questions answered in the study

1.3. Executive summary

Chapter 2: Introduction

2.1. Market definitions

2.2. Global market trends

2.3. Global drivers

2.4. Global challenges

2.5. Revenue based on product type - 2018 (USD Bn)

2.6. Revenue based on end-user type - 2018 (USD Bn)

2.7. Value chain of self-monitoring blood glucose devices market

Chapter 3: Global Self-monitoring Blood Glucose Devices Market
Overview

3.1. Market overview

3.1.a. Global market revenue - (2015-2017) (USD Bn)

3.1.b. Global forecast market revenue - (2018-2023) (USD Bn)

3.1.c. Geography-wise market revenue - (2018, 2023) (USD Bn)

Chapter 4: Global Self-monitoring Blood Glucose Devices Market -
Segment Insights

4.1. Global testing strips market

4.1.a. Revenue - (2015-2023) (USD Bn)

4.1.b. Trends

4.1.c. Drivers

4.2. Global glucometers market

4.2.a. Revenue - (2015-2023) (USD Bn)

4.2.b. Trends

4.2.c. Drivers

4.3. Global other product segments market

4.3.a. Revenue - (2015-2023) (USD Bn)

4.3.b. Trends

4.3.c. Drivers

Chapter 5: Global Self-monitoring Blood Glucose Devices Market -
Based on Regions

5.1. North America

5.1.a. Overview

5.1.b. Revenue - (2015-2023) (USD Bn)

5.1.c. Key Highlights

5.2. Europe

5.2.a. Overview

5.2.b. Revenue - (2015-2023) (USD Bn)

5.2.c. Key Highlights

5.3. Asia-Pacific

5.3.a. Overview

5.3.b. Revenue - (2015-2023) (USD Bn)

5.3.c. Key Highlights

5.4. The Middle Esat and Africa

5.4.a. Overview

5.4.b. Revenue - (2015-2023) (USD Bn)

5.4.c. Key Highlights

5.5. Latin America

5.4.a. Overview

5.4.b. Revenue - (2015-2023) (USD Bn)

5.4.c. Key Highlights

Chapter 6: Market Share of Companies

6.1. Global self-monitoring blood glucose devices market share of
companies

6.1.a. Overview

Chapter 7: Competitive Landscape

7.1. Roche Holding AG

7.1.a. Company snapshot

7.1.b. Products

7.1.c. Initiatives

7.1.d. Growth strategy

7.2. LifeScan Inc.

7.3. Abbott Laboratories

7.4. Ypsomed AG

7.5. B. Braun Melsungen AG

Chapter 8: Self-monitoring Blood Glucose Devices Start-up Firms

8.1. Ascensia Diabetes Care

8.2. DiaMonTech

8.3. Nemaura Medical Inc.

8.4. Noviosense B.V.

Chapter 9: Conclusion

Chapter 10: Appendix

10.1. List of tables

10.2. Research methodology

For more information about this report visit https://www.researchandmarkets.com/r/glueh2

View source version on businesswire.com: https://www.businesswire.com/news/home/20190426005362/en/